Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association Between COVID-19 Exposure and Self-reported Compliance With Public Health Guidelines Among Essential Employees at an Institution of Higher Education in the US.
Nelson TL, Fosdick BK, Biela LM, Schoenberg H, Mast S, McGinnis E, Young MC, Lynn L, Fahrner S, Nolt L, Dihle T, Quicke K, Gallichotte EN, Fitzmeyer E, Ebel GD, Pabilonia K, Ehrhart N, VandeWoude S. Nelson TL, et al. Among authors: lynn l. JAMA Netw Open. 2021 Jul 1;4(7):e2116543. doi: 10.1001/jamanetworkopen.2021.16543. JAMA Netw Open. 2021. PMID: 34287634 Free PMC article.
Undergraduate Teaching During COVID-19.
Gentry-Weeks C, Ciaravola DR, Barker M, Long K, Lynn L, Pidcoke H, Quintana K, Withers B. Gentry-Weeks C, et al. Among authors: lynn l. Appl Biosaf. 2022 Sep 1;27(3):153-168. doi: 10.1089/apb.2022.0023. Epub 2022 Sep 14. Appl Biosaf. 2022. PMID: 36779199 Free PMC article.
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase 2b multinational, randomised, double-blind, placebo-controlled ARROYO trial.
Altrichter S, Giménez-Arnau AM, Bernstein JA, Metz M, Bahadori L, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Suárez E, Walton C, Datto CJ; ARROYO Study Investigators. Altrichter S, et al. Br J Dermatol. 2024 Feb 17:ljae067. doi: 10.1093/bjd/ljae067. Online ahead of print. Br J Dermatol. 2024. PMID: 38367194
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.
Guttman-Yassky E, Bahadori L, Brooks L, Clark KL, Grindebacke H, Ho CN, Katial R, Pham TH, Walton C, Datto CJ; HILLIER study group†. Guttman-Yassky E, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1211-e1214. doi: 10.1111/jdv.19195. Epub 2023 Jun 12. J Eur Acad Dermatol Venereol. 2023. PMID: 37178404 Clinical Trial. No abstract available.
110 results